Clinical Trials Logo
NCT number NCT00000346
Study type Interventional
Source National Institute on Drug Abuse (NIDA)
Contact
Status Active, not recruiting
Phase Phase 4

Clinical Trial Summary

The purpose of this study is to characterize the cognitive performance of methamphetamine abusers by comparing them with cocaine abusers and normal controls.


Clinical Trial Description

n/a


Study Design

Primary Purpose: Treatment


Related Conditions & MeSH terms


See also
Status Clinical Trial Phase
 Completed NCT02232789 - Abuse Liability and Human Pharmacology of Mephedrone Phase 1
 Completed NCT01449565 - Extended-Release Naltrexone to Treat Methamphetamine Dependence in Men Who Have Sex With Men (MSM) Phase 2
 Completed NCT00247572 - Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories Phase 2
 Active, not recruiting NCT00100074 - To Assess the Safety and Tolerability of 7.5, 15 and 30 mg of Sublingual Lobeline. - 1 Phase 1
 Active, not recruiting NCT00033072 - Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1 Phase 1
 Completed NCT00990067 - Interaction Between Duloxetine and 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) Phase 1
 Completed NCT02797990 - Conflict Between Maternal Autonomy and Child Health in Substance-use N/A
 Recruiting NCT01899313 - A Cognitive Behavioral Therapy-Based Text Message Intervention for Methamphetamine Dependence N/A
 Active, not recruiting NCT00265278 - Assessment of Interactions Between Intravenous Methamphetamine and Modafinil - 1 Phase 1
 Active, not recruiting NCT00000350 - Effects of Stimulant Dependence on Human Striatal Dopamine System - 15 Phase 1
 Active, not recruiting NCT00089440 - Assessment of Interactions Between Methamphetamine and Aripiprazole - 1 Phase 1
 Active, not recruiting NCT00040040 - Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1 Phase 1
 Completed NCT00040053 - Ondansetron for the Treatment of Methamphetamine Dependence - 1 Phase 2
 Completed NCT00895804 - Pharmacological Interaction Between Pindolol and MDMA (3,4-Methylenedioxymethamphetamine) Phase 1
 Completed NCT01386177 - Pharmacological Interaction Between Doxazosin and Methylenedioxymethamphetamine (MDMA) Phase 1
 Completed NCT01136278 - Pharmacological Interaction Between Clonidine and Methylenedioxymethamphetamine (MDMA) Phase 1
 Completed NCT00069251 - Bupropion for the Treatment of Methamphetamine Dependence - 1 Phase 2
 Completed NCT01270672 - Pharmacological Interaction Between Carvedilol and Methylenedioxymethamphetamine (MDMA) N/A
 Completed NCT00856323 - Contingency Management for Methamphetamine Abstinence and HIV Post-Exposure Prophylaxis in Men Who Have Sex With Men Phase 2
 Completed NCT00254306 - Functional Brain Imaging in Recreational Users of Ecstasy N/A